Literature DB >> 20704012

Visual symptoms in the Heidenhain variant of Creutzfeldt-Jakob Disease.

Jason R Cornelius1, Christopher J Boes, Gena Ghearing, Jacqueline A Leavitt, Neeraj Kumar.   

Abstract

BACKGROUND AND
PURPOSE: The distinguishing feature in Heidenhain variant Creutzfeldt-Jakob Disease (HvCJD) is the presence of visual symptoms preceding the appearance of other clinical manifestations. The purpose of this report is to describe the broad range of visual symptomatology in a patient with HvCJD.
METHODS: The authors describe the clinical, neuroimaging, and EEG features of a 51-year-old man with progressive visual symptoms that were most likely due to HvCJD. Migraine and epilepsy were initial diagnostic considerations.
RESULTS: Our patient presented with progressive visual decline and superimposed spells of visual dysfunction that had complex characteristics. Evolution of an abnormal signal in the parieto-occipital cortex on diffusion weighted MRI, changes on EEG, and clinical course were consistent with HvCJD.
CONCLUSIONS: HvCJD should be considered in all patients who present with unexplained visual phenomena. A remarkable spectrum of visual disturbances can be seen. Close follow-up as well as serial MRI and EEG can help clarify the underlying disease process. Diffusion-weighted and FLAIR sequences should be included in the MRI protocol.

Entities:  

Mesh:

Year:  2009        PMID: 20704012     DOI: 10.1111/j.1552-6569.2008.00294.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  2 in total

Review 1.  An overview of human prion diseases.

Authors:  Muhammad Imran; Saqib Mahmood
Journal:  Virol J       Date:  2011-12-24       Impact factor: 4.099

2.  Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.

Authors:  Simone Baiardi; Sabina Capellari; Anna Ladogana; Silvia Strumia; Mario Santangelo; Maurizio Pocchiari; Piero Parchi
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.